Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent BoosterNew England Journal of Medicine, 2023-01, Vol.388 (2), p.183-185 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2214293 ;PMID: 36546661Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNature communications, 2021-06, Vol.12 (1), p.3587-3587, Article 3587 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-23942-y ;PMID: 34117252Full text available |
|
4 |
Material Type: Article
|
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster VaccinationNew England Journal of Medicine, 2022-03, Vol.386 (11), p.1088-1091 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119912 ;PMID: 35081298Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variantCell host & microbe, 2021-04, Vol.29 (4), p.516-521.e3 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.03.009 ;PMID: 33798491Full text available |
|
6 |
Material Type: Article
|
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole BloodEmerging infectious diseases, 2017-01, Vol.23 (1), p.99-101 [Peer Reviewed Journal]COPYRIGHT 2017 U.S. National Center for Infectious Diseases ;COPYRIGHT 2017 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2301.161394 ;PMID: 27748649Full text available |
|
7 |
Material Type: Article
|
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesNature immunology, 2021-10, Vol.22 (10), p.1306-1315 [Peer Reviewed Journal]2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. ;COPYRIGHT 2021 Nature Publishing Group ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01021-0 ;PMID: 34417590Full text available |
|
8 |
Material Type: Article
|
Enhancing SIV-specific immunity in vivo by PD-1 blockadeNature, 2009-03, Vol.458 (7235), p.206-210 [Peer Reviewed Journal]2009 INIST-CNRS ;COPYRIGHT 2009 Nature Publishing Group ;COPYRIGHT 2009 Nature Publishing Group ;Copyright Nature Publishing Group Mar 12, 2009 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;EISSN: 1476-4679 ;DOI: 10.1038/nature07662 ;PMID: 19078956 ;CODEN: NATUASFull text available |
|
9 |
Material Type: Article
|
Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron VariantCell Reports Medicine, 2022-07, Vol.3 (7), p.100679-100679, Article 100679 [Peer Reviewed Journal]2022 ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Authors 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100679 ;PMID: 35798000Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungsImmunity (Cambridge, Mass.), 2021-03, Vol.54 (3), p.542-556.e9 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2021.02.001 ;PMID: 33631118Full text available |
|
11 |
Material Type: Article
|
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantCell reports. Medicine, 2022-02, Vol.3 (2), p.100529-100529, Article 100529 [Peer Reviewed Journal]2022 ;2022. ;2022. 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100529 ;PMID: 35233550Full text available |
|
12 |
Material Type: Article
|
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1The Lancet infectious diseases, 2012-12, Vol.12 (12), p.966-976 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(12)70243-8 ;PMID: 23174382 ;CODEN: LANCAOFull text available |
|
13 |
Material Type: Article
|
Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humansProceedings of the National Academy of Sciences - PNAS, 2020-07, Vol.117 (30), p.17957-17964 [Peer Reviewed Journal]Copyright National Academy of Sciences Jul 28, 2020 ;2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1906613117 ;PMID: 32661157Full text available |
|
14 |
Material Type: Article
|
Durability of immune responses to mRNA booster vaccination against COVID-19The Journal of clinical investigation, 2023-05, Vol.133 (10), p.1-10 [Peer Reviewed Journal]COPYRIGHT 2023 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2023 ;2023 Arunachalam et al. 2023 Arunachalam et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI167955 ;PMID: 36951954Full text available |
|
15 |
Material Type: Article
|
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infectionPloS one, 2021-08, Vol.16 (8), p.e0256482-e0256482 [Peer Reviewed Journal]COPYRIGHT 2021 Public Library of Science ;2021 Lapp et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Lapp et al 2021 Lapp et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0256482 ;PMID: 34449792Full text available |
|
16 |
Material Type: Article
|
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialThe Lancet infectious diseases, 2022-08, Vol.22 (8), p.1210-1220 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00052-4 ;PMID: 35568049Full text available |
|
17 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in micenpj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518Full text available |
|
18 |
Material Type: Article
|
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like ParticlesThe Journal of infectious diseases, 2011-03, Vol.203 (5), p.610-619 [Peer Reviewed Journal]Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011 ;2015 INIST-CNRS ;ISSN: 0022-1899 ;ISSN: 1537-6613 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiq105 ;PMID: 21282192 ;CODEN: JIDIAQFull text available |
|
19 |
Material Type: Article
|
Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infectionThe Journal of clinical investigation, 2022-12, Vol.132 (23), p.1-3 [Peer Reviewed Journal]COPYRIGHT 2022 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Dec 2022 ;2022 Linderman et al. 2022 Linderman et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI164303 ;PMID: 36256473Full text available |
|
20 |
Material Type: Article
|
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus VaccineThe Journal of infectious diseases, 2011-07, Vol.204 (1), p.164-173 [Peer Reviewed Journal]Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011 ;2015 INIST-CNRS ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jir199 ;PMID: 21628671 ;CODEN: JIDIAQFull text available |